March 10 (Reuters) - BioNTech SE 22UAy.DE:
EXPECTS 2025 TOTAL REVENUES BETWEEN EUR 1.7 BILLION AND EUR 2.2 BILLION
CASH AND CASH EQUIVALENTS PLUS SECURITY INVESTMENTS OF EUR 17.4 BILLION AS OF DECEMBER 31, 2024
CEO - EXPECT 2025 TO BE A DATA-RICH YEAR WITH MULTIPLE IMPORTANT UPDATES FROM OUR PRIORITY PROGRAMS, WHICH WE BELIEVE HAVE DISRUPTIVE POTENTIAL AND COULD IMPROVE STANDARD OF CARE, IF SUCCESSFULLY DEVELOPED AND APPROVED
OUTLOOK 2025: RESEARCH AND DEVELOPMENT EXPENSES EUR 2,600 MILLION - EUR 2,800 MILLION, SG&A EXPENSES EUR 650 MILLION - EUR 750 MILLION
OUTLOOK 2025: CAPITAL EXPENDITURES FOR OPERATING ACTIVITIES EUR 250 MILLION - EUR 350 MILLION
Further company coverage: 22UAy.DE